EnGeneIC, Australia, has developed the EnGene delivery vehicle, that are bacterially-derived cells loaded with chemotherapeutic agents. These nanoshells can specifically deliver either nucleotides or other cytotoxic drugs without causing any systemic toxicity.

The New Millennium Indian Technology Leadership Initiative program of the Council of Scientific and Industrial Research India is promoting public-private collaborative ventures for developing nanotechnologies that target drugs exactly where they are needed in the human body.

India-based Jupiter Bioscience has initiated a project for the development of anti-cancer chemotherapeutic agents for effective treatment of lung cancer. Aiming to devise a novel formulation based on nanobiotechnology, the company is focused on the development, optimization and characterization of ligand (RGD peptides) targeted nano-constructs encapsulating anti-cancer chemotherapeutic agents (Gemcitabine) for effective treatment of lung cancer.